Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Nuclear Transmutation03:20

Nuclear Transmutation

Nuclear transmutation is the conversion of one nuclide into another. It can occur by the radioactive decay of a nucleus, or the reaction of a nucleus with another particle. The first manmade nucleus was produced in Ernest Rutherford’s laboratory in 1919 by a transmutation reaction, the bombardment of one type of nuclei with other nuclei or with neutrons. Rutherford bombarded nitrogen-14 atoms with high-speed α particles from a natural radioactive isotope of radium and observed protons being...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Bilateral renoureteral plasmacytoma. An unusual presentation in a young patient with multiple myeloma.

Revista espanola de medicina nuclear e imagen molecular·2026
Same authorSame journal

Integration of Nuclear Medicine in Multidisciplinary Committees: Involvement, perception, and areas for improvement. Results of a national survey.

Revista espanola de medicina nuclear e imagen molecular·2026
Same author

Therapeutic impact of 18F-PSMA-1007 PET/MRI in staging intermediate/high-risk prostate cancer patients: Imaging biomarkers and radiomic analysis associated with tumor aggressiveness.

Revista espanola de medicina nuclear e imagen molecular·2026
Same author

Characterization of indeterminate renal masses using immunoPET with 89Zr-Girentuximab: presentation of two clinical cases.

Revista espanola de medicina nuclear e imagen molecular·2026
Same author

Early diagnosis of synchronous bilateral breast cancer using bilateral breast-selective prone-position [18F]FDG PET/MRI.

Revista espanola de medicina nuclear e imagen molecular·2026
Same author

Feasibility of transperineal prostate biopsy guided by fusion of [18F]F-PSMA-1007 PET/MRI with real-time transrectal ultrasound. Prostate cancer classification using imaging biomarkers and radiomics in PIRADS 3 lesions.

Revista espanola de medicina nuclear e imagen molecular·2025
Same journal

Prediction of PD-L1 expression in gastric cancer using <sup>18</sup>F-FDG PET/CT radiomics.

Revista espanola de medicina nuclear e imagen molecular·2026
Same journal

Prognostic value of radionics based on <sup>18</sup>F-FDG PET/CT in Hodgkin lymphoma: A systematic review.

Revista espanola de medicina nuclear e imagen molecular·2026
Same journal

Cardiac amyloidosis: An update on nuclear cardiology in diagnosis and follow-up.

Revista espanola de medicina nuclear e imagen molecular·2026
Same journal

Dynamic salivary gland scintigraphy in rheumatoid arthritis: Association with disease activity.

Revista espanola de medicina nuclear e imagen molecular·2026
See all related articles

Related Experiment Video

Updated: May 18, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

THE NUCLEAR ONCOLOGIST

J R Garcia1, P Paredes2, E Riera1

  • 1CETIR ASCIRES; Cátedra UB-CETIR/QUAES de Diagnóstico y Terapia Metabólica.

Revista Espanola De Medicina Nuclear E Imagen Molecular
|May 16, 2026
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Related Experiment Videos

Last Updated: May 18, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015